Air Liquide Healthcare Pty Ltd - Inogen One G3 Concentrator Recall

A recall notice for Inogen One G3 Concentrator supplied by Air Liquide Healthcare Pty Ltd as when connected to a fully charged 8-cell battery as its only power source, an operating condition may cause an abrupt shut down of the Inogen One G3 Portable Oxygen Concentrator (POC).

Air Liquide Healthcare Pty Ltd - Inogen One G3 Concentrator

PRA No.

2020/18229

Date published

27 Feb 2020

Product description

Inogen One G3 Concentrator
Portable lightweight medical oxygen machine

Part Numbers: 19252750, 19252534, 19285707, 19285618, 19285718, 19285621, 19285334, 19252739, 19285727, 19284756, 19252747, 19285626, 19285728, 19252726, 19284685, 19282715, 19285619, 19252733

ARTG 225950
(Air Liquide Healthcare Pty Ltd - Stationary oxygen concentrator)

What are the defects?

When connected to a fully charged 8-cell battery as its only power source, an operating condition may cause an abrupt shut down of the Inogen One G3 Portable Oxygen Concentrator (POC).

If no action is taken, the POC may become unresponsive for up to one minute, after which it will behave as though a battery was just connected with a standard flash screen on display. The POC will then be ready for another startup. If powered on again, this cycle may need to be repeated until the 8-cell battery has been adequately discharged allowing the POC to operate as normal.

What are the hazards?

Risk of interruption to the supply of oxygen to users, which may lead to health complications.

What should consumers do?

Customers are advised that arrangements will be made for the products to be repaired and/or replaced. An Air Liquide Healthcare representative will contact customers via phone to initiate the replacement POC, and collect the affected concentrator.

For further information, contact Air Liquide Healthcare Customer Service Centre on 1300 360 202.

Supplier

Air Liquide Healthcare Pty Ltd

Traders who sold this product

Health Clinics, Chemists and Pharmacies

Where the product was sold

Australian Capital Territory

New South Wales

Queensland

South Australia

Victoria

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category

Personal

Bookmark/Search this post